Shingles Vaccine Market Drivers Shaping Future Growth, Revenue USD 6.02 Billion by 2029 | CAGR 10.1 percentage

Forecast Increase in Revenue:

Shingles Vaccine Market was valued at USD 3.06 Billion in 2022, and it is expected to reach USD 6.02 Billion by 2029, exhibiting a CAGR of 10.1 % during the forecast period (2023-2029)

Shingles Vaccine Market Overview:

The Shingles Vaccine Market is experiencing substantial growth due to the increasing prevalence of shingles, particularly among the aging population. Shingrix, a highly effective recombinant zoster vaccine, is the primary vaccine used to prevent shingles and its complications, including postherpetic neuralgia (PHN). The growing awareness of the importance of vaccination, combined with favorable government policies and the availability of effective vaccines like Shingrix, is driving market expansion. As healthcare systems worldwide focus on preventive care, the demand for shingles vaccines continues to rise, ensuring sustained market growth.

𝐘𝐨𝐮𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐈𝐬 𝐉𝐮𝐬𝐭 𝐚 𝐂𝐥𝐢𝐜𝐤 𝐀𝐰𝐚𝐲: https://www.maximizemarketresearch.com/request-sample/124937/

Drivers in the Shingles Vaccine Market:

The primary drivers of the Shingles Vaccine Market include the high efficacy of vaccines like Shingrix, which has demonstrated over 90% effectiveness in preventing shingles and PHN among older adults. The increasing incidence of shingles, particularly among the elderly and immunocompromised individuals, is also a significant factor driving the market. Additionally, the growing awareness campaigns by healthcare organizations and government agencies to promote vaccination have further contributed to the market's expansion. The inclusion of shingles vaccines in national immunization programs in several countries is another key driver, as it ensures widespread vaccine accessibility.

Shingles Vaccine Market Trends:

One of the prominent trends in the Shingles Vaccine Market is the increasing preference for recombinant vaccines like Shingrix over older live attenuated vaccines such as Zostavax. This shift is largely due to the superior efficacy and safety profile of recombinant vaccines. Another trend is the rising investment in research and development by pharmaceutical companies to develop new and improved shingles vaccines. As the global population ages, the demand for shingles vaccination is expected to increase, leading to continuous innovation and product development in the market.

𝐍𝐞𝐞𝐝 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧? 𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐀𝐛𝐨𝐮𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 + 𝐆𝐫𝐚𝐩𝐡𝐬 𝐇𝐞𝐫𝐞: https://www.maximizemarketresearch.com/inquiry-before-buying/124937/

Shingles Vaccine Market Opportunities:

The Shingles Vaccine Market presents several growth opportunities, particularly in emerging markets where vaccination rates are currently low. As healthcare infrastructure improves and disposable incomes rise in these regions, there is significant potential for market expansion. Additionally, the ongoing development of new vaccines and the potential for their inclusion in immunization programs across more countries offer further growth prospects. The increasing focus on preventive healthcare and the growing awareness of the long-term benefits of vaccination are also likely to create new opportunities for market players.

What is Shingles Vaccine Market Regional Insight?

Regionally, North America is expected to dominate the Shingles Vaccine Market, driven by the presence of major pharmaceutical companies, favorable reimbursement policies, and high vaccination rates. The United States, in particular, has seen widespread adoption of Shingrix, supported by strong public health campaigns and government recommendations. In contrast, the Asia Pacific region is anticipated to experience the fastest growth, fueled by rising healthcare spending, improved healthcare policies, and a large population at risk of developing shingles. Europe follows North America as a significant market, with increasing awareness and adoption of shingles vaccines, particularly among the elderly population. Other regions, including South America and the Middle East & Africa, are also expected to witness growth, albeit at a slower pace, due to increasing awareness and improving healthcare infrastructure.

𝐂𝐮𝐫𝐢𝐨𝐮𝐬 𝐭𝐨 𝐩𝐞𝐞𝐤 𝐢𝐧𝐬𝐢𝐝𝐞? 𝐆𝐫𝐚𝐛 𝐲𝐨𝐮𝐫 𝐬𝐚𝐦𝐩𝐥𝐞 𝐜𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐧𝐨𝐰: https://www.maximizemarketresearch.com/request-sample/124937/

Segmentation Analysis of the Shingles Vaccine Market:

by Drug Type

Zostavax
Shingrix
Others

by Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Others

by Vaccine Type

Recombinant Vaccine
Live Attenuated Vaccine

Who is the largest manufacturers of Shingles Vaccine Market worldwide?

1. GlaxoSmithKline plc.
2. Merck & Co., Inc.
3. SK chemicals
4. Green Cross Corp
5. CanSinoBIO
6. Geneone Life Science
7. Vaccitech
8. Pfizer
9. Sanofi
10. CSL Behring
11. Curevo Inc.
12. GeneOne Life Science Inc.

𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞 𝐀𝐛𝐨𝐮𝐭 𝐓𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.maximizemarketresearch.com/market-report/shingles-vaccine-market/124937/

Key Offerings:

Past Market Size and Competitive Landscape
Shingles Vaccine Market Size, Share, Size & Forecast by different segment
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
Shingles Vaccine Market Segmentation - A detailed analysis by Product
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Recommendations

Explore our top-performing reports on the latest trends:

♦ White Biotechnology Market: https://www.maximizemarketresearch.com/market-report/global-white-biotechnology-market/98059/

♦ Connected Healthcare Market: https://www.maximizemarketresearch.com/market-report/connected-healthcare-market/121763/

♦ Kiosk Operating System Market: https://www.maximizemarketresearch.com/market-report/kiosk-operating-system-market/148318/

♦ Makeup Remover Market: https://www.maximizemarketresearch.com/market-report/global-makeup-remover-market/19695/

♦ global Lupus Market: https://www.maximizemarketresearch.com/market-report/global-lupus-market/65753/

♦ Global Motion Control Market: https://www.maximizemarketresearch.com/market-report/global-motion-control-market/29918/

♦ Gyroscope Market: https://www.maximizemarketresearch.com/market-report/gyroscope-market/146048/

♦ Femtech Market: https://www.maximizemarketresearch.com/market-report/femtech-market/124781/

♦ global Orphan Drugs Market: https://www.maximizemarketresearch.com/market-report/orphan-drugs-market/342/

♦ Research Antibodies Market: https://www.maximizemarketresearch.com/market-report/global-research-antibodies-market/15831/

Contact Maximize Market Research:

MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
✆ +91 9607365656
🖂 sales@maximizemarketresearch.com
🌐 www.maximizemarketresearch.com

About Maximize Market Research:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.